Lv73
3883 积分 2021-08-09 加入
Multimodal clocks of human aging
21天前
已完结
Recent advances in the discovery of PKMYT1-targeting drugs: a patent review (2021–2025)
1个月前
已完结
Discovery of Novel Inhibitors for WD Repeat‐Containing Protein 5 (WDR5)‐MYC Protein–Protein Interaction
1个月前
已完结
Structure–Activity and Structure–Degradation Relationship Studies of 2-Amino-6-(benzimidazol-2-ylmethyl)-N9-heteroarylpurines as Potent and Selective CDK12/13 Inhibitors and Cyclin K Degraders
1个月前
已完结
The Multi-Faceted Landscape of TEAD Inhibition: a 2017–2025 Patent and Literature Review
1个月前
已完结
Artificial Intelligence for Drug Target and Pathway Identification, Assessment, Validation, and Indication Expansion
1个月前
已完结
Target identification and assessment in the era of AI
1个月前
已完结
Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Inhibitors of CDK8 for the Treatment of Cancer
1个月前
已完结
Discovery of a Novel Macrocyclic Noncovalent CDK7 Inhibitor for Cancer Therapy
1个月前
已完结
Identification of Novel pan-KRAS Inhibitors via Structure-Based Drug Design, Scaffold Hopping, and Biological Evaluation
1个月前
已完结
皖公网安备34019202002308
